SBI Securities’s Dare Bioscience DARE Stock Holding History

SBI Securities’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$610	Buy	715 +70	+11%	+$82	﹤0.01%	3049
2026 Q2	$1.36K	Hold	645	–	–	﹤0.01%	2692
2026 Q1	$1.17K	Buy	645 +70	+12%	+$120	﹤0.01%	2603
2025 Q4	$1.11K	Sell	575 -1	-0.2%	-$2	﹤0.01%	2607
2025 Q3	$1.21K	Buy	576 +1	+0.2%	+$2	﹤0.01%	2610
2025 Q2	$1.37K	Hold	575	–	–	﹤0.01%	2546
2025 Q1	$1.66K	Hold	575	–	–	﹤0.01%	2374
2024 Q4	$1.79K	Buy	+575	New	+$1.99K	﹤0.01%	2357

Other funds holding DARE

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

SBI Securities's DARE Position: Q3 2026 in Review

SBI Securities increased its Dare Bioscience (DARE) stake by 11% in Q3 2026, buying an estimated $82 and bringing the position to 715 shares worth $610. The position accounts for ﹤0.01% of the portfolio, ranked #3049.

SBI Securities first reported a position in DARE in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.79K in Q4 2024. 5 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

SBI Securities held 715 shares of Dare Bioscience worth $610 as of Q3 2026.
SBI Securities bought 70 Dare Bioscience shares in Q3 2026, an estimated $82.
Dare Bioscience made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3049 holding.
SBI Securities first reported a position in Dare Bioscience in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Dare Bioscience position peaked at $1.79K in Q4 2024.
5 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.